Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL)from MyBiosource |
|
| MBS1212944-002mgBaculovirus | 0.02mg(Baculovirus): 1125.00 EUR |
|
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL)from MyBiosource |
|
| MBS1212944-002mgEColi | 0.02mg(E-Coli): 705.00 EUR |
|
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL)from MyBiosource |
|
| MBS1212944-002mgYeast | 0.02mg(Yeast): 875.00 EUR |
|
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL)from MyBiosource |
|
| MBS1212944-01mgEColi | 0.1mg(E-Coli): 845.00 EUR |
|
Recombinant Pseudomonas oleovorans Outer membrane protein AlkL (alkL)from MyBiosource |
|
| MBS1212944-01mgYeast | 0.1mg(Yeast): 1025.00 EUR |
|
AUTO KJDL DISTN ALKLI H2O ACID FRPfrom Borosil |
|
| BLFAKDI05000000000 | 1 Unit: Ask for price |
|
AUTO KJDL DISTN ALKLI FRP TOUCH ATTfrom Borosil |
|
| BLFAKDI06000000000 | 1 Unit: Ask for price |
|
ALK (L1152R), Activefrom MyBiosource |
|
| MBS516537-0005mg | 0.005mg: 320.00 EUR |
|
ALK (L1152R), Activefrom MyBiosource |
|
| MBS516537-001mg | 0.01mg: 390.00 EUR |
|
ALK (L1152R), Activefrom MyBiosource |
|
| MBS516537-5x001mg | 5x0.01mg: 1500.00 EUR |
|
ALK (L1196M), Activefrom MyBiosource |
|
| MBS516542-0005mg | 0.005mg: 320.00 EUR |
|
ALK (L1196M), Activefrom MyBiosource |
|
| MBS516542-001mg | 0.01mg: 390.00 EUR |
|
ALK (L1196M), Activefrom MyBiosource |
|
| MBS516542-5x001mg | 5x0.01mg: 1500.00 EUR |
|
ALK (L1196M G1202R), Activefrom MyBiosource |
|
| MBS516548-0005mg | 0.005mg: 320.00 EUR |
|
ALK (L1196M G1202R), Activefrom MyBiosource |
|
| MBS516548-001mg | 0.01mg: 390.00 EUR |
|
ALK (L1196M G1202R), Activefrom MyBiosource |
|
| MBS516548-5x001mg | 5x0.01mg: 1500.00 EUR |
|
ALK4290from MedChemExpress |
|
| HY-136788 | 10 mg: 3571.48 EUR |
|
|
Description: ALK4290 (AKST4290) is a potent and orally active CCR3 inhibitor extracted from patent US20130261153A1, compound Example 2, with a Ki of 3.2 nM for hCCR3[1]. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism[2][3]. |
|
ALK4290from MyBiosource |
|
| MBS5785051-10mg | 10mg: 1155.00 EUR |
|
ALK4290from MyBiosource |
|
| MBS5785051-5mg | 5(mg: 595.00 EUR |
|
ALK4290from MyBiosource |
|
| MBS5785051-5x10mg | 5x10(mg: 5055.00 EUR |
|
ALK4290from TargetMol Chemicals |
|
| T36620-10mg | 10mg: Ask for price |
|
|
Description: ALK4290 |
|
ALK4290from TargetMol Chemicals |
|
| T36620-1g | 1g: Ask for price |
|
|
Description: ALK4290 |
|
ALK4290from TargetMol Chemicals |
|
| T36620-1mg | 1mg: Ask for price |
|
|
Description: ALK4290 |
|
ALK4290from TargetMol Chemicals |
|
| T36620-50mg | 50mg: Ask for price |
|
|
Description: ALK4290 |
|
ALK4290from TargetMol Chemicals |
|
| T36620-5mg | 5mg: Ask for price |
|
|
Description: ALK4290 |
|
ALK-001from MyBiosource |
|
| MBS5779496-5mg | 5(mg: 915.00 EUR |
|
ALK-001from MyBiosource |
|
| MBS5779496-5x5mg | 5x5(mg: 3970.00 EUR |
|
ALK-001from TargetMol Chemicals |
|
| T29867-10mg | 10mg: Ask for price |
|
|
Description: ALK-001 |
|
ALK-001from TargetMol Chemicals |
|
| T29867-1g | 1g: Ask for price |
|
|
Description: ALK-001 |
|
ALK-001from TargetMol Chemicals |
|
| T29867-1mg | 1mg: Ask for price |
|
|
Description: ALK-001 |
|
ALK-001from TargetMol Chemicals |
|
| T29867-50mg | 50mg: Ask for price |
|
|
Description: ALK-001 |
|
ALK-001from TargetMol Chemicals |
|
| T29867-5mg | 5mg: Ask for price |
|
|
Description: ALK-001 |
|
ALK4290 (dihydrochloride)from MedChemExpress |
|
| HY-136788A | Get quote: Ask for price |
|
|
Description: ALK4290 dihydrochloride (AKST4290 dihydrochlorid) is a potent and orally active CCR3 inhibitor extracted from patent US20130261153A1, compound Example 2, with a Ki of 3.2 nM for hCCR3[1]. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism[2][3]. |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), 1mg/mLfrom Biotium |
|
| BNUM2766-50 | 1uL: 396.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), 0.2mg/mLfrom Biotium |
|
| BNUB2766-100 | 1uL: 225.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), 0.2mg/mLfrom Biotium |
|
| BNUB2766-500 | 1uL: 485.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
BDP 558/568 alkynefrom MedKoo Biosciences |
|
| 558798 | 5.0mg: 390.00 EUR |
|
BDP 581/591 alkynefrom MedKoo Biosciences |
|
| 558799 | 5.0mg: 390.00 EUR |
|
BDP 630/650 alkynefrom MedKoo Biosciences |
|
| 558800 | 5.0mg: 390.00 EUR |
|
BDP 650/665 alkynefrom MedKoo Biosciences |
|
| 558801 | 5.0mg: 390.00 EUR |
|
BDP 630/650 alkyne, 1 mgfrom Lumiprobe |
|
| A54B0 | 1 mg: 129.60 EUR |
|
BDP 581/591 alkyne, 1 mgfrom Lumiprobe |
|
| A64B0 | 1 mg: 129.60 EUR |
|
BDP 558/568 alkyne, 1 mgfrom Lumiprobe |
|
| A74B0 | 1 mg: 129.60 EUR |
|
BDP 650/665 alkyne, 1 mgfrom Lumiprobe |
|
| A84B0 | 1 mg: 129.60 EUR |
|
BDP 630/650 alkyne, 5 mgfrom Lumiprobe |
|
| B54B0 | 5 mg: 218.40 EUR |
|
BDP 581/591 alkyne, 5 mgfrom Lumiprobe |
|
| B64B0 | 5 mg: 218.40 EUR |
|
BDP 558/568 alkyne, 5 mgfrom Lumiprobe |
|
| B74B0 | 5 mg: 218.40 EUR |
|
BDP 650/665 alkyne, 5 mgfrom Lumiprobe |
|
| B84B0 | 5 mg: 218.40 EUR |
|
BDP 630/650 alkyne, 25 mgfrom Lumiprobe |
|
| D54B0 | 25 mg: 379.20 EUR |
|
BDP 581/591 alkyne, 25 mgfrom Lumiprobe |
|
| D64B0 | 25 mg: 379.20 EUR |
|
BDP 558/568 alkyne, 25 mgfrom Lumiprobe |
|
| D74B0 | 25 mg: 379.20 EUR |
|
BDP 650/665 alkyne, 25 mgfrom Lumiprobe |
|
| D84B0 | 25 mg: 379.20 EUR |
|
BDP 630/650 alkyne, 10 mgfrom Lumiprobe |
|
| C54B0 | 10 mg: 294.00 EUR |
|
BDP 581/591 alkyne, 10 mgfrom Lumiprobe |
|
| C64B0 | 10 mg: 294.00 EUR |
|
BDP 650/665 alkyne, 10 mgfrom Lumiprobe |
|
| C84B0 | 10 mg: 294.00 EUR |
|
BDP 558/568 alkyne, 10 mgfrom Lumiprobe |
|
| C74B0 | 10 mg: 294.00 EUR |
|
E. coli 0157:H7 -ALK PHOSfrom GenWay Biotech |
|
| GWB-94A691 | 0.1 mg: Ask for price |
|
BDP 630/650 alkyne, 100 mgfrom Lumiprobe |
|
| F54B0 | 100 mg: 1006.80 EUR |
|
BDP 581/591 alkyne, 100 mgfrom Lumiprobe |
|
| F64B0 | 100 mg: 1006.80 EUR |
|
BDP 558/568 alkyne, 100 mgfrom Lumiprobe |
|
| F74B0 | 100 mg: 1006.80 EUR |
|
BDP 650/665 alkyne, 100 mgfrom Lumiprobe |
|
| F84B0 | 100 mg: 1006.80 EUR |
|
BDP 630/650 alkyne, 50 mgfrom Lumiprobe |
|
| E54B0 | 50 mg: 601.20 EUR |
|
BDP 581/591 alkyne, 50 mgfrom Lumiprobe |
|
| E64B0 | 50 mg: 601.20 EUR |
|
BDP 558/568 alkyne, 50 mgfrom Lumiprobe |
|
| E74B0 | 50 mg: 601.20 EUR |
|
BDP 650/665 alkyne, 50 mgfrom Lumiprobe |
|
| E84B0 | 50 mg: 601.20 EUR |
|
Recombinant Rat ALK-2 / ACVR1 / ALK2 Protein (Fc tag)from MyBiosource |
|
| MBS2547460-02mg | 0.2mg: 1095.00 EUR |
|
Recombinant Rat ALK-2 / ACVR1 / ALK2 Protein (Fc tag)from MyBiosource |
|
| MBS2547460-5x02mg | 5x0.2mg: 4930.00 EUR |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF568 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC682766-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF568 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC682766-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF594 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC942766-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF594 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC942766-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF647 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC472766-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF647 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC472766-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF488A conjugate, 0.1mg/mLfrom Biotium |
|
| BNC882766-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF488A conjugate, 0.1mg/mLfrom Biotium |
|
| BNC882766-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), Biotin conjugate, 0.1mg/mLfrom Biotium |
|
| BNCB2766-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), Biotin conjugate, 0.1mg/mLfrom Biotium |
|
| BNCB2766-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF640R conjugate, 0.1mg/mLfrom Biotium |
|
| BNC402766-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF640R conjugate, 0.1mg/mLfrom Biotium |
|
| BNC402766-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF405S conjugate, 0.1mg/mLfrom Biotium |
|
| BNC042766-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK1/2766R), CF405S conjugate, 0.1mg/mLfrom Biotium |
|
| BNC042766-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246 (ALK/1503), 1mg/mLfrom Biotium |
|
| BNUM1503-50 | 50uL: 396.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK/1504), 1mg/mLfrom Biotium |
|
| BNUM1504-50 | 1uL: 396.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK/1031), 1mg/mLfrom Biotium |
|
| BNUM1031-50 | 1uL: 396.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK/1032), 1mg/mLfrom Biotium |
|
| BNUM1032-50 | 1uL: 396.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246 (ALK/1503), 0.2mg/mLfrom Biotium |
|
| BNUB1503-100 | 100uL: 225.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246 (ALK/1503), 0.2mg/mLfrom Biotium |
|
| BNUB1503-500 | 500uL: 485.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
ALK (Anaplastic Lymphoma Kinase) / CD246(ALK/1504), 0.2mg/mLfrom Biotium |
|
| BNUB1504-100 | 1uL: 225.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
